SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Deobiosciences Inc. – ‘C-AR’ for 12/31/21

On:  Thursday, 4/28/22, at 10:35am ET   ·   For:  12/31/21   ·   Accession #:  1669191-22-441   ·   File #:  20-27847

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/28/22  Deobiosciences Inc.               C-AR       12/31/21    2:13M                                    NetCapital Funding … Inc

Annual Report   —   Form C-AR   —   Regulation Crowdfunding

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: C-AR        Annual Report -- primary_doc.xml                    HTML      6K 
 2: EX-99       Miscellaneous Exhibit -- deobiocar                   PDF  10.34M 


‘C-AR’   —   Annual Report — primary_doc.xml




        

This ‘C-AR’ Document is an XML Data File that may be rendered in various formats:

  Form C    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
SEC Info rendering:  Annual Report
 
schemaVersion:

Form C: Filer Information

Filer CIK:
0001523215 
Filer CCC:
XXXXXXXX 
Period:

12/31/21 

Is this a LIVE or TEST Filing?Radio button checked LIVE Radio button not checked TEST
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption?Checkbox not checked
Would you like a Return Copy?Checkbox not checked

Submission Contact Information

Name:
 
Phone Number:
 
Contact E-Mail Address:
 
Notify via Filing Website only?Checkbox not checked

Form C: Issuer Information

Issuer Information

Name of Issuer:

DEOBIOSCIENCES INC 

Legal Status of Issuer:

Form:

Corporation 

Jurisdiction of Incorporation/Organization:

DELAWARE  

Date of Incorporation/Organization:

2/3/00 

Physical Address of Issuer:

Address 1:

4045 FIVE FORKS TRICKUM RD. 

Address 2:

B8-243 

City:

LILBURN 

State/Country:

GEORGIA  

Mailing Zip/Postal Code:

30047 

Website of Issuer:

www.deobiosciences.com 

Form C: Annual Report Disclosure Requirements

Annual Report Disclosure Requirements

Current Number of Employees:

1.00 

Total Assets Most Recent Fiscal Year-end:

1043.00 

Total Assets Prior Fiscal Year-end:

1151.00 

Cash and Cash Equivalents Most Recent Fiscal Year-end:

1043.00 

Cash and Cash Equivalents Prior Fiscal Year-end:

1151.00 

Accounts Receivable Most Recent Fiscal Year-end:

0.00 

Accounts Receivable Prior Fiscal Year-end:

0.00 

Short-term Debt Most Recent Fiscal Year-end:

3927.00 

Short-term Debt Prior Fiscal Year-end:

4035.00 

Long-term Debt Most Recent Fiscal Year-end:

292873.00 

Long-term Debt Prior Fiscal Year-end:

245588.00 

Revenue/Sales Most Recent Fiscal Year-end:

0.00 

Revenue/Sales Prior Fiscal Year-end:

0.00 

Cost of Goods Sold Most Recent Fiscal Year-end:

0.00 

Cost of Goods Sold Prior Fiscal Year-end:

0.00 

Taxes Paid Most Recent Fiscal Year-end:

1677.00 

Taxes Paid Prior Fiscal Year-end:

0.00 

Net Income Most Recent Fiscal Year-end:

-47287.00 

Net Income Prior Fiscal Year-end:

-19427.00 

Form C: Signature

Signature

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned.

Issuer:

DEOBIOSCIENCES INC 

Signature:

John Adamson 

Title:

CEO 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

Catherine Bryant 

Title:

Board Director 

Date:

3/3/21 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

Kathyrn Smith 

Title:

Board Director 

Date:

3/3/21 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

John Adamson 

Title:

Board Director 

Date:

3/3/21 


Top
Filing Submission 0001669191-22-000441   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 19, 1:47:40.1pm ET